A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Medetomidine Impurity 13 - Request Quote

Picture of Medetomidine Impurity 13

Medetomidine Impurity 13

SZ CAT No:SZ-M070038
CAS No
NA
Mol.F.
C13H16N2 : HCl
Mol.Wt.
200.3 : 36.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Medetomidine Impurity 13 is chemically 4-(1-(3,5-Dimethylphenyl)ethyl)-1H-imidazole hydrochloride. Medetomidine Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Medetomidine Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Medetomidine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Medetomidine Impurity 13

Purchase Medetomidine Impurity 13

Medetomidine Impurity 13 suppliers

Medetomidine Impurity 13 manufacturers

Medetomidine Impurity 13 price

Order Medetomidine Impurity 13

Enquire Medetomidine Impurity 13

Medetomidine Impurity 13 cost

Medetomidine Impurity 13 Supplier

Medetomidine Impurity 13 Distributor

Medetomidine Impurity 13 for Method Validation

Medetomidine Reference Standard

Medetomidine Impurity 13 for ANDA Filing

Medetomidine Impurity 13 for Forced Degradation Studies

Medetomidine Impurity 13 Identification Standards

Medetomidine Impurity 13 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,